Lipopplysaccharide conjugate vaccines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241941, 42419611, 42419711, 4242081, 530403, 530807, A61K 39385, A61K 3921, C07K 1700

Patent

active

058243100

ABSTRACT:
The present invention relates to lipopolysaccharides from Brucella abortus and their use as carriers in vaccines for humans and animals. In particular, the present invention relates to conjugate molecules having a carrier molecule of purified lipopolysaccharide from B. abortus coupled to an antigenic component of an infectious organism.

REFERENCES:
patent: 4693891 (1987-09-01), Collins et al.
patent: 4789544 (1988-12-01), Nelson et al.
patent: 4831126 (1989-05-01), Bundle et al.
patent: 4834975 (1989-05-01), Siadak et al.
patent: 4929604 (1990-05-01), Munford et al.
patent: 5006463 (1991-04-01), Cherwonogrodzky
Journal of Biological Response Modifiers 3:1-9 copyright 1984 Raven Press, New York, pp. 1-9.
Biological Activities of Monophosphoryl Lipid A, Edgard Ribi, John Cantrell, Tim Feldner, Kent Myres and Jon Peterson, Ribi ImmunoChem Research, Inc., Hamilton, Montana 59840, pp. 9-13.
Federation of American Societies for Experimental Biology, 75th Annual Meeting, Atlanta, Georgia, Apr. 21-25, 1991, Part II, pp. 1 and 2. Abstract No. 3670 Goldstein et al.
Phillips et al American Journal of Veterinary Research, vol. 50, No. 3, Mar. 1989, pp. 311-318.
Analytical Biochemistry 119, 115-119 (1982) A sensitive Silver Stain for Detecting Lipopolysaccharides in Polyacrylamide Gels, Chao-Ming Tsai and Carl E. Frasch.
The Journal of Biological Chemistry, vol. 350, No. 8, Issue of Apr. 25, pp. 2911-2919, 1975, Fractions of Lipopolysaccharide from Escherichia coli 0111:B4 Prepared by Two Extraction Procedures, Morrison and Leive.
Journal of Biological Response Modifiers 6:99-107, copyright 1987 Raven Press, New York, "The Adjuvant Properties of a Nontoxic Monophosphoryl Lipid A in Hyporesponsive and Aging Mice", Tomai, Solem, Johnson and Ribi.
Ribi Biological Response Modifiers, Ribi Immunochem Research, Inc.
Immunopharmacology of Infectioous Diseases: Vaccine Adjuvants and Modulators of Non-Specific Resistance, pp. 101-112, copyright 1987 Alan R. Liss, Inc. Ribi et al.
Modulation of Humoral and Cell Mediated Immune Responses By a Structurally Established Nontoxic Lipid A, pp. 407-420, Ribi et al, in Immunobiology and Immunopharamacology of bacterial Endotoxins, Szentivanyi et al Eds, Plenum Press New York, 1996.
Technological Advances in Vaccine Development, pp. 443-454, copyright 1988 Alan R. Liss, Molecularly Engineered Microbial Immunostimulators, Jon A. Rudbach, John L. Cantrell and J. Terry Ulrich, pp. 443-454.
The Journal of Immunology, Copyright 1984 by The American Association of Immunologists, vol. 133, No. 6, Dec. 1984, Newborn And Wiskott-Aldrich Patient B Cells Can Be Activated By TNP-Brucella Abortus:Evidence . . . Antigen In Humans, B. Golding, A. V. Muchmore and R. M. Blaese.
The Journal of Immunology, Copyright 1981 by The Williams & Wilkins Co., vol. 127, No. 1, Jul. 1981, "Human Lymphocytes Can Generate Thymus-Independent As Well . . . In Vitro.sup.1 " B. Golding et al.
Gregory Gregoriadis eds Immunological Adjuvants and Vaccines by Rietschel et al "Bacterial endotoxins: Relationship between Chemical Structure and Biological Activity" Ser. A vol. 179:61-74.
Lambden et al (1982) J. Immunol. Methods 48:233-240.
Louis et al (1979) Springer Semin. Immunopatho 12:215-228.
Ribi et al (1984) Reviews of Infectious Dis. 6(4):567-572.
Galanos et al (1977) International Review of Biochemistry, Biochemistry of Lipids II, vol. 14:239-333.
Berger et al. (1969) Proc. Soc. Exp. Biol. Med. 131:1376-1381.
Alonso-Urmeneta et al (1988) J. Clin. Microbiol. 26(12):2642-2646.
Golding et al (1991) AIDS Research Human Retroviruses 7(5):435-446.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Lipopplysaccharide conjugate vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipopplysaccharide conjugate vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipopplysaccharide conjugate vaccines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-241761

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.